Tumor immunology: The glass is half full

[1] CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) : 1555 - 1564

[2] Gene transfer of Fas ligand induces tumor regression in vivo [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13862 - 13867

[3] Tumor antigen presentation changing the rules [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (02) : 70 - 74

[4] Dendritic cells and the control of immunity [J]. NATURE, 1998, 392 (6673) : 245 - 252

[5] Mechanisms of the graft-versus-leukemia reaction [J]. STEM CELLS, 1997, 15 (04) : 248 - 258

[6] CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) : 183 - 189

[7] Tumor antigens [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) : 681 - 683

[8] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1

[9] Therapy with cultured T cells: Principles revisited [J]. IMMUNOLOGICAL REVIEWS, 1997, 157 : 177 - 194

[10] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J]. CELL, 1992, 71 (07) : 1093 - 1102

[1] CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) : 1555 - 1564

[2] Gene transfer of Fas ligand induces tumor regression in vivo [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13862 - 13867

[3] Tumor antigen presentation changing the rules [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (02) : 70 - 74

[4] Dendritic cells and the control of immunity [J]. NATURE, 1998, 392 (6673) : 245 - 252

[5] Mechanisms of the graft-versus-leukemia reaction [J]. STEM CELLS, 1997, 15 (04) : 248 - 258

[6] CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) : 183 - 189

[7] Tumor antigens [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) : 681 - 683

[8] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1

[9] Therapy with cultured T cells: Principles revisited [J]. IMMUNOLOGICAL REVIEWS, 1997, 157 : 177 - 194

[10] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J]. CELL, 1992, 71 (07) : 1093 - 1102